Indication
Post-exposure anthrax prevention
Post-exposure anthrax prevention is a clinical prophylactic management state indicated for asymptomatic individuals following confirmed or suspected exposure to aerosolized or viable spores of *Bacillus anthracis*. Read more about Post-exposure anthrax prevention
250 drugs 120 manufacturers
Drugs that treat it
Common Post-exposure anthrax prevention therapies.
CIPRO I.V. (ciprofloxacin lactate)
ADOXA PAK (doxycycline monohydrate)
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
CIPROFLOXACIN (ciprofloxacin lactate)
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPost-exposure anthrax prevention is a clinical prophylactic management state indicated for asymptomatic individuals following confirmed or suspected exposure to aerosolized or viable spores of *Bacillus anthracis*.
The condition addresses potential inhalational, cutaneous, or gastrointestinal infection across pediatric and adult populations prior to the onset of overt clinical disease.
Pathophysiologically, dormant spores taken up by host macrophages can persist in mediastinal lymph nodes or tissues and germinate over days to weeks, subsequently producing lethal and edema toxins that drive severe bacteremia, systemic toxemia, and tissue necrosis.
Preventative intervention aims to neutralize circulating toxins and eradicate vegetative bacilli during germination, thereby halting the progression to life-threatening systemic anthrax.
- fda.gov
Post-exposure anthrax prevention is a clinical prophylactic management state indicated for asymptomatic individuals following confirmed or suspected exposure to aerosolized or viable spores of *Bacillus anthracis*
- fda.gov
Post-exposure anthrax prevention is a clinical prophylactic management state indicated for asymptomatic individuals following confirmed or suspected exposure to aerosolized or viable spores of *Bacillus anthracis*
- nih.gov
The condition addresses potential inhalational, cutaneous, or gastrointestinal infection across pediatric and adult populations prior to the onset of overt clinical disease
- cdc.gov
The condition addresses potential inhalational, cutaneous, or gastrointestinal infection across pediatric and adult populations prior to the onset of overt clinical disease Pathophysiologically, dormant spores taken up by host macrophages can persist in mediastinal lymph nodes or tissues and germinate over days to weeks, subsequently producing lethal and edema toxins that drive severe bacteremia, systemic toxemia, and tissue necrosis Preventative intervention aims to neutralize circulating toxin...
- nih.gov
Pathophysiologically, dormant spores taken up by host macrophages can persist in mediastinal lymph nodes or tissues and germinate over days to weeks, subsequently producing lethal and edema toxins that drive severe bacteremia, systemic toxemia, and tissue necrosis
- cdc.gov
Preventative intervention aims to neutralize circulating toxins and eradicate vegetative bacilli during germination, thereby halting the progression to life-threatening systemic anthrax
Personalize your experience
Follow Post-exposure anthrax prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.